U.S. Markets closed

Regeneron Pharmaceuticals, Inc. (REGN)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
521.22+5.30 (+1.03%)
At close: 4:00PM EDT

521.22 0.00 (0.00%)
After hours: 4:33PM EDT

People also watch
ALXNBIIBCELGVRTXBMRN
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Revenue12/31/201612/31/201512/31/2014
Total Revenue4,860,4274,103,7282,819,557
Cost of Revenue299,694392,709205,018
Gross Profit4,560,7333,711,0192,614,539
Operating Expenses
Research Development2,052,2951,620,5771,271,353
Selling General and Administrative1,177,697838,526519,267
Non Recurring---
Others---
Total Operating Expenses---
Operating Income or Loss1,330,7411,251,916823,919
Income from Continuing Operations
Total Other Income/Expenses Net6,269-12,578-25,312
Earnings Before Interest and Taxes1,337,0101,239,338798,607
Interest Expense7,19514,24137,372
Income Before Tax1,329,8151,225,097761,235
Income Tax Expense434,293589,041423,109
Minority Interest---
Net Income From Continuing Ops895,522636,056338,126
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income895,522636,056338,126
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares895,522636,056338,126